tirzepatide news 2025 New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss WHO adds weight-loss, diabetes drugs

Nor does it explain another surprising finding from the study: men taking these weight-loss treatments appeared to face three times the risk of vision loss compared to women

Typically, when youve eaten enough, you should get a signal to the brain that youre full

Vascular cell senescence contributes to blood-brain barrier breakdown

Side Effects of Skin Whitening Injections There are no prominent gluta shots side effects but in rare cases some patients can observe Short term redness or swelling at the treatment site

The peptide's predictable dose-response and extended stability in culture media have made it a preferred growth factor supplement in CHO cell culture, stem cell expansion, and primary cell isolation protocols across hundreds of published studies